54 213 54 213 (Lithium 150 mg)
Pill imprint 54 213 54 213 has been identified as Lithium carbonate 150 mg.
Lithium is used in the treatment of bipolar disorder; depression; borderline personality disorder; schizoaffective disorder; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 54 213 54 213
- 150 mg
- 4.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Roxane Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Red No. 40
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|00054-2526||Roxane Laboratories, Inc.|
Note: Inactive ingredients may vary.
More about lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.